Justine’s focus on integrating psycho-spiritual care, including psychedelic therapies, for those with life-limiting illness to help reduce existential distress and improve quality of life.

Every person deserves to meet the end of life with access to holistic, compassionate, and transformative care - yet for many Australians, this is not the reality. For instance, the literature tells us that around 51% of cancer patients will experience existential distress that conventional medicine is unable to alleviate. This isn't just a statistic, it’s a mirror held up to a widespread, unmet need in our healthcare system.

As the co-founder of End Wise, a not-for-profit organisation, she leads efforts to transform end-of-life care through the safe and legal use of psychedelic-assisted therapy.

End Wise is committed to advancing psychedelic-assisted therapy within palliative care by fostering education, research, policy engagement, and collaboration. Our advocacy is grounded in a deep understanding of the therapeutic potential of psychedelics to alleviate suffering and enhance quality of life for patients and their caregivers.

Through normalising the therapeutic use of psychedelics, End Wise empowers clinicians, patients, and families with informed choices towards end of life—helping to reshape the landscape of compassionate care.